Novel β-lactam/β-lactamase inhibitor combinations show limited activity against Indian carbapenem-resistant Pseudomonas aeruginosa isolates due to conundrum of diverse resistance mechanisms

MeSH terms

• Anti-Bacterial Agents* / pharmacology
• Carbapenems* / pharmacology
• Humans
• India
• Microbial Sensitivity Tests*
• Pseudomonas Infections* / drug therapy
• Pseudomonas Infections* / microbiology
• Pseudomonas aeruginosa* / drug effects
• Pseudomonas aeruginosa* / genetics
• Pseudomonas aeruginosa* / isolation & purification
• beta-Lactam Resistance
• beta-Lactamase Inhibitors* / pharmacology
• beta-Lactamases* / genetics
• beta-Lactams / pharmacology